Drawing for MOZOBIL

USPTO serial 78527902

MOZOBIL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SHIH, SALLY
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MOZOBIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard D. Allison

Genzyme Corporation15 Pleasant Street ConnectorLegal DepartmentFramingham, MA 01701

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and ophthalmic diseases, including age related macular degeneration and diabetic retinopathyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 9, 2009MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 9, 2009ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 9, 2008GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 9, 2008GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 9, 2008CNSISUSPENSION INQUIRY WRITTEN—
Aug 5, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 5, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 5, 2008GNSLLETTER OF SUSPENSION E-MAILED—
Feb 5, 2008CNSLSUSPENSION LETTER WRITTEN—
Jan 31, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2008ALIEASSIGNED TO LIE—
Dec 18, 2007ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 21, 2007GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 21, 2007GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 21, 2007CNSISUSPENSION INQUIRY WRITTEN—
Aug 17, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 28, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 28, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 2, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Feb 2, 2007CNSLSUSPENSION LETTER WRITTEN—
Feb 2, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 2, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2007ALIEASSIGNED TO LIE—
Jan 9, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 10, 2006GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 10, 2006CNSISUSPENSION INQUIRY WRITTEN—
Jan 10, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Jan 10, 2006CNSLSUSPENSION LETTER WRITTEN—
Jan 10, 2006GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 10, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 11, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2005DOCKASSIGNED TO EXAMINER—
Dec 15, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance